Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2015
At a glance
- Drugs Exenatide (Primary)
- Indications Gestational diabetes
- Focus Therapeutic Use
- 20 Aug 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 06 Aug 2013 Actual initiation date changed from 1 Mar 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 06 Aug 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.